P. Rougier

11.1k citations
115 papers · 8.0k · 2 hit papers · h-index 42

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Lung Cancer Research Studies
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 53
    • Cancer Treatment and Pharmacology 25
    • Pancreatic and Hepatic Oncology Research 19
    • Gastric Cancer Management and Outcomes 21
    • Lung Cancer Treatments and Mutations 18

P. Rougier

114 papers receiving 7.8k citations

P. Rougier's Hit Papers

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial 2011 · 1.5k citations
1.5k0+6+12Years since publication4008001.2k

Peers

P. Rougier
Comparison fields: 5 of 132
  • Oncology 5.4k
  • Hepatology 1.2k
  • Gastroenterology 789
  • Pulmonary and Respiratory Medicine 3.3k
  • Surgery 2.4k
Replace David Malka with:
David Malka France
Jörg T. Hartmann Germany
Charles A. Staley United States
David A. Kooby United States
Min‐Hee Ryu South Korea
Benjamin Tan United States
Philippe Rougier France
Irene Floriani Italy
George A. Poultsides United States
Leonard L. Gunderson United States
P. Rougier relative to David Malka France David Malka's profile →
Citations per field
00.5×1.5×2.1×
David Malka · 1×
Citations per year

Countries citing papers authored by P. Rougier

Since Specialization
Citations

This map shows the geographic impact of P. Rougier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rougier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rougier more than expected).

Fields of papers citing papers by P. Rougier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rougier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rougier. The network helps show where P. Rougier may publish in the future.

Co-authors

The 25 scholars most cited alongside P. Rougier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Rougier Line = papers co-authored together P. Rougier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Hit paper breakdown →
20111484
2
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
Hit paper breakdown →
2008501
3 2002422
4 1999368
5 2002356
6 2004312
7 2012299
8 2012281
9 2008281
10 2009254
11 2007233
12 2001162
13 1996159
14 2009156
15 2005148
16 2005107
17 2004101
18 200396
19 200596
20 200295

About P. Rougier

P. Rougier is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Surgery and Epidemiology, having authored 115 papers that have together received 8.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (53 papers), Cancer Treatment and Pharmacology (25 papers), Gastric Cancer Management and Outcomes (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Pancreatic and Hepatic Oncology Research (19 papers), Lung Cancer Treatments and Mutations (18 papers), Metallic Glasses and Amorphous Alloys (14 papers) and Neuroendocrine Tumor Research Advances (14 papers). The work is most often cited by research in Oncology (5.4k citations), Hepatology (1.2k citations), Gastroenterology (789 citations), Pulmonary and Respiratory Medicine (3.3k citations) and Surgery (2.4k citations). P. Rougier has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Eric Van Cutsem, P Lasser, Olivier Bouché, Marc Ychou, Laurent Bedenne, Emmanuel Mitry, Michel Ducreux, Valérie Boige, Jean‐Pierre Pignon and G. Lebreton. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer and Journal of Magnetism and Magnetic Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact